Nurix

VP/SVP, Global Development Leader

Nurix • $210K — $250K *
Brisbane, CA 94005In-Person
Pharmaceuticals & Biotech
8 - 10 years of experience
Today
Be an Early Applicant
Job Overview by Ladders

Qualifications

  • MD, board certified in hematology/oncology
  • 10+ years of clinical trial experience in pharmaceuticals, especially in Ph3
  • Clinical research experience from academic settings considered
  • Proven leadership and excellent communication skills
  • Ability to thrive in fast-paced environments with changing priorities
  • Experience leading high-performing teams
  • Hands-on leadership style preferred

Responsibilities

  • Lead cross-functional Program teams through Ph1-3 and approval phases
  • Set direction and execute goals for clinical therapies portfolio
  • Develop and communicate program plans with asset teams
  • Facilitate strategic alignment across teams and executives
  • Identify challenges and implement mitigations during trials
  • Oversee development and refinement of Clinical Development Plan
  • Provide medical oversight and data review for clinical trials
  • Support regulatory discussions and activities throughout clinical process
  • Interact with investigators and opinion leaders for trial facilitation
  • Refine processes for clinical protocol design and data collection
  • Present clinical data to executive and medical audiences

Benefits

  • Collaborative and dynamic work culture
  • Opportunities for leadership and career growth
  • Supportive environment encouraging diverse perspectives
  • Focus on results and innovative problem-solving
Full Job Description
Vice President / Senior Vice President, Global Development Leader (Bexobrutideg)

We are seeking a brilliant, organized and highly motivated leader who will provide strategic and tactical medical leadership and will deliver key clinical and scientific leadership to clinical development programs while ensuring the highest standard for safety and compliance with regulatory requirements and standard procedures. The ideal candidate should have experience working in a fast-paced dynamic environment. The successful candidate will report to the Chief Medical Officer. The responsibilities of this leader are listed below.
  • Lead one or more Program teams comprised of functional representatives from Clinical Development (Clinical Operations, Medical Monitoring, Clinical Science), Research and Translational Medicine, Regulatory, Technical Operations, Quality, and Commercial from phase 1 through phase 3 and through approval and launch; serve as the single point of accountability for the BTK Program Global Development Team (GDT), and to create and drive key program decisions through appropriate governance forums, where appropriate
  • As a member of the Clinical Executive Management Team, partner with stakeholders to set clear direction and execute against goals for a portfolio of clinical stage therapies, ensuring the development and execution of program strategy is in line with corporate strategy and goals
  • Drive the development and communication of program plans and development plan in partnership with the asset teams and program management
  • Facilitate cross-functional communication; drive strategic and operational alignment with the Program team, functional leads, and Executive Management Team
  • Identify challenges and risks and prepare the team with mitigations to navigate through technical and program challenges as they arise
  • Develop or participate in the refinement/update of the Clinical Development Plan (CDP); act as or oversee the clinical leads for protocols and supportive activities to meet the CDP objectives
  • Provide medical oversight for ongoing clinical trials including regular review of clinical data to improve understanding of the molecule profile, including but not limited to safety and activity
  • Provide clinical oversight for Company operational staff and contract research organizations (CROs) in all areas related to the execution of therapeutic programs
  • Provide and or oversee training and ongoing input to all members of the clinical team on medical and scientific issues related to the appropriate therapeutic field
  • Provide medical support for all relevant regulatory discussions and activities, such as IND's and NDA/MAAs
  • Interact with principal investigators and opinion leaders to facilitate clinical trials research
  • Refine and or establish processes and methods for design and implementation of applicable clinical protocols, data collection systems and final reports
  • Data presentation to executive leaders, internal and external medical colleagues in one on one or large group settings (50+).

Required Qualifications
  • MD, board certified preferably in hematology/oncology
  • Requires at least 10 years' clinical trial experience in the setting of pharmaceutical industry with demonstrated experience and involvement in clinical trial design or execution. In particular, Ph3 clinical trial planning and execution.
  • Relevant clinical research experience in academic settings will be reviewed in light of clinical development experience
  • Excellent communicator with proven leadership skills and the ability to interact in a cross functional environment
  • Comfortable in a fast-paced small company environment with minimal direction and able to adjust workload based upon changing priorities
  • Proven leadership experience leading high performing teams and individuals
  • Hands on leadership approach will be best suited for this critical role
  • Experience working in a highly productive and high achieving collaboration

Fit with Nurix Culture and Values
  • Strong team orientation; highly collaborative
  • Solutions and results-oriented focus
  • Hands-on approach; resourceful and open to diverse points of view

About Nurix

Nurix Therapeutics is a biotechnology company that is focused on the discovery, development, and commercialization of small molecule therapies that modulate the ubiquitin proteasome system (UPS) for the treatment of cancer and other diseases. The company's proprietary drug discovery platform is based on the use of DNA-encoded libraries (DELs) to identify small molecules that selectively bind to E3 ligases, which are key enzymes in the UPS. Nurix's lead drug candidate, NX-2127, is a first-in-class small molecule inhibitor of the CBL-B E3 ligase that is being developed for the treatment of solid tumors and hematological malignancies. The company was founded in 2013 and is headquartered in San Francisco, California.
Learn more about Nurix
Size
135 employees
Market Cap
$486 million
Industry
Pharmaceuticals & Biotech
Net Income
-$43.2 million
Founded
2009
Revenue
$17.8 million
NASDAQ
NRIX
* Ladders Estimates

Similar Jobs

Ad banner background

Get Ready For Your
Next Interview

More Jobs at Nurix

More Pharmaceuticals & Biotech Jobs

Find similar VP/SVP, Global Development Leader jobs:

NationwideBrisbane, CA